Charles W Newhall III

Chuck has been at the forefront of innovation in healthcare since co-founding NEA in 1977, with a focus on healthcare services, healthcare information technology and biopharmaceutical investments. He has served as a director of more than 50 venture-backed companies, and currently serves on the boards of Interfusio, Neuropace, Supernus Pharmaceuticals, and Vitae Pharmaceuticals. His prior board memberships include AMERIGROUP, Bravo Health, Caremark, Chomerics, CoGenesys, Comp Health, Genetic Therapy, LifeMetrix, Life Technologies, PatientKeeper, Russ Pharmaceuticals, Senseonics, Scandipharm, Sepracor, Surgical Health, and Zymark Corporation. Chuck played an integral role in the broader industry's maturation, not only as an investor but as a thought leader and advocate. He founded the Mid-Atlantic Venture Capital Association (MAVA), which now has over 80 venture capital firms that are members, and is one of the most active regional venture associations in the country. He is Chairman Emeritus of MAVA. Chuck continues to be deeply engaged as a venture capital industry advocate and is frequently invited to speak to organizations and institutions about the state of the industry. Recently he worked with Peter Bancroft, a well-known former venture capitalist, the NVCA, and Harvard University to record the oral histories of leading VCs so that the histories of the firms will be not be lost. Sixty interviews have been conducted or scheduled so far. He is a Trustee of the Baltimore Museum of Art and a Member of the University of Maryland, Baltimore County Board of Visitors. Before co-founding NEA, Chuck was Vice President of T. Rowe Price Associates (Vice President of their New Horizons Fund). He served in Vietnam, commanding an independent platoon including an initial reconnaissance of Hamburger Hill. His decorations include the Silver Star and Bronze Star V (1st OLC.). He received his MBA from the Harvard University Graduate School of Business and his BA in English Literature with honors from the University of Pennsylvania.